Cargando…
A Current Review of Targeted Therapeutics for Ovarian Cancer
Difficult to detect, ovarian cancer typically presents at an advanced stage. Significant progress has been achieved in the treatment of ovarian cancer with therapeutics focused on DNA replication or cell division. However, despite sensitivity to induction chemotherapy the majority of patients will d...
Autores principales: | Campos, Susana M., Ghosh, Sue |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804109/ https://www.ncbi.nlm.nih.gov/pubmed/20069122 http://dx.doi.org/10.1155/2010/149362 |
Ejemplares similares
-
Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review
por: Amano, Tsukuru, et al.
Publicado: (2019) -
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
por: Moffitt, Laura, et al.
Publicado: (2019) -
An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
por: Alexandrova, Elena, et al.
Publicado: (2020) -
Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021) -
BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
por: Clark-Knowles, Katherine V., et al.
Publicado: (2010)